Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CRHBP | P24387 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.43 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16158449 | 1.00 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1 | |
| SCHEMBL10065965 | 1.00 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1 | |
| SCHEMBL21129113 | 1.00 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1 | |
| SCHEMBL10065405 | 1.00 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1 | |
| SCHEMBL11891632 | 0.97 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1 | |
| SCHEMBL5373892 | 0.97 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1 | |
| SCHEMBL13608535 | 0.95 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1 | |
| SCHEMBL14016097 | 0.95 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1 | |
| SCHEMBL21977063 | 0.93 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1 | |
| SCHEMBL14016090 | 0.93 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8227096-B2 | Arylamine compound and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-07-24 | — | — | US | disclosed |
| US-8227096-B2 | Arylamine compound and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-07-24 | — | — | US | disclosed |
| US-20110133171-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-06-09 | — | — | US | disclosed |
| US-20110133171-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-06-09 | — | — | US | disclosed |
| US-7867632-B2 | Arylamine compound and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD (JP) | 2011-01-11 | — | — | US | disclosed |
| US-7867632-B2 | Arylamine compound and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD (JP) | 2011-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110133171-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | NAT1, TRDMT1, BMI1 | ALDH1A1 78/4885L3MBTL1 743/4885CYP1A2 473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.